Team:EPF Lausanne/Project

From 2010.igem.org

(Difference between revisions)
(Overview)
(Overview)
Line 33: Line 33:
-
This bacteria would express an [https://2010.igem.org/Team:EPF_Lausanne/Project_immuno immunotoxin] and specific [https://2010.igem.org/Team:EPF_Lausanne/Project_immuno proteins] to kill the (i)Plasmodium falciparum(/i) or prevent its entry into the epithelium.
+
This bacteria would express an [https://2010.igem.org/Team:EPF_Lausanne/Project_immuno immunotoxin] and specific [https://2010.igem.org/Team:EPF_Lausanne/Project_immuno proteins] to kill the <i>Plasmodium falciparum</i> or prevent its entry into the epithelium.
     [[Image:all_team.png|200px|caption]]                [[Image:hunting.png|200px|caption]]
     [[Image:all_team.png|200px|caption]]                [[Image:hunting.png|200px|caption]]
-
The immunotoxin and the proteins then fight the (i)Plasmodium falciparum (/i) and thus prevent the mosquito infection.
+
The immunotoxin and the proteins then fight the <i>Plasmodium falciparum </i> and thus prevent the mosquito infection.

Revision as of 16:45, 25 October 2010



Overview

caption

The aim of our project is to help stopping the propagation of Malaria. To do so, we chose to act on the mosquito. Indeed, if we prevent the mosquito from being infected by malaria, it won't be able to transmit the parasite to healthy humans.

caption

Our idea is to engineer Asaia, a bacterium that is naturally present in the mosquito's intestinal tract.

Asaia project overview.png

Gut.png


This bacteria would express an immunotoxin and specific proteins to kill the Plasmodium falciparum or prevent its entry into the epithelium.


    caption                caption

The immunotoxin and the proteins then fight the Plasmodium falciparum and thus prevent the mosquito infection.



caption


So... ASAIA is the pink power against malaria.....







For a playful overview of our project, you can watch our great movie iGEM EPFL movie

caption

Further improvements

The next step would be to test Asaia that expresses the immunotoxin in mosquitoes. The efficiency of the immunotoxin could then be measured by counting the number of oocysts outside the mosquito's gut. We are currently collaborating with the Pasteur Institute in Paris to make further test on mosquitoes with our bacteria but unfortunately the results won't be available before this year's jamboree.

Some modeling experiments should also be done to try to measure the impact of introducing our modified bacteria in mosquitoes populations. According to the [http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VRT-4V3K67R-B&_user=164550&_coverDate=12%2F09%2F2008&_rdoc=1&_fmt=high&_orig=search&_origin=search&_sort=d&_docanchor=&view=c&_acct=C000013218&_version=1&_urlVersion=0&_userid=164550&md5=52110befa7e6dce2da04feff33af38dc&searchtype=a literature], Asaia is transmitted from parent to offspring and also from one individual to the other but further measurement should be made to see how quick the spreading would be. Using these values, it might be possible to find out the best way to infect the most mosquitoes without risking an uncontrolled expansion of the bacteria population.


wrap bottom